Holen Sie sich die Stockscreener-App
1.44
0.69%
-0.01
Handel nachbörslich:
1.44
Schlusskurs vom Vortag:
$1.45
Offen:
$1.485
24-Stunden-Volumen:
17.87M
Relative Volume:
1.66
Marktkapitalisierung:
$918.74M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.50
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+5.88%
1M Leistung:
+16.13%
6M Leistung:
-45.25%
1J Leistung:
-68.00%
1-Tages-Spanne:
$1.44
$1.55
1-Wochen-Bereich:
$1.31
$1.55
52-Wochen-Spanne:
$1.09
$4.825
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.44 | 925.12M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.88 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.87 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.91 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
661.32 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.32 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell |
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation Names Harout Semerjian as New CEO to Lead Commercialization of RYTELO - Yahoo Finance
Will Geron Corporation stock go up soon2025 Risk Factors & Daily Chart Pattern Signals - Newser
Best data tools to analyze Geron Corporation stockForecast Cut & Expert Curated Trade Setup Alerts - Newser
What data driven models say about Geron Corporation’s futureMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Visual analytics tools that track Geron Corporation performanceQuarterly Market Review & Community Supported Trade Ideas - Newser
Visual trend scoring systems applied to Geron CorporationForecast Cut & Capital Efficient Trade Techniques - Newser
How high can Geron Corporation stock price go in 2025 - Newser
Real time social sentiment graph for Geron CorporationEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser
Q3 Earnings Forecast for Geron Issued By Leerink Partnrs - Defense World
Geron Corporation’s SWOT analysis: biotech stock faces growth hurdles amid positive outlook - Investing.com
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Geron Corporation Surges: CEO Appointment and Q2 Triumph - StocksToTrade
News impact scoring models applied to Geron Corporation2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Geron Corporation Breaks Below Key Support LevelQuarterly Portfolio Report & Fast Exit/Entry Strategy Plans - 선데이타임즈
Geron Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for Geron Earnings - Defense World
Is Geron Corporation Forming a Bottom PatternLong Hold Safe Return Strategy Reviewed - beatles.ru
Q1 Earnings Forecast for Geron Issued By Wedbush - Defense World
Geron's Positive Momentum and Strategic Leadership Drive Buy Rating Amid Rytelo Demand Growth. - AInvest
Geron Corporation (NASDAQ:GERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Geron Corporation shares rise 1.56% after-hours after granting 11,000,000 stock options to new CEO. - AInvest
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron: I Think We've Seen This Movie Before (NASDAQ:GERN) - Seeking Alpha
A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $4 to $5 - 富途牛牛
Geron 2025 Q2 Earnings Beats Expectations with 80% EPS Improvement - AInvest
Geron Corporation (NASDAQ:GERN) Q2 2025 Earnings Call Transcript - Insider Monkey
Geron: Q2 Earnings Snapshot - Huron Daily Tribune
Geron Corp (GERN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Geron (GERN) Q2 Revenue Jumps 5,477% - sharewise.com
Semerjian to lead Geron - BioCentury
Geron reports Q2 EPS (2c), consensus (3c) - TipRanks
Geron Corporation Set to Release Q2 Financial Results, Eyes Market Reaction - StocksToTrade
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises - Investing.com
Geron appoints Harout Semerjian as CEO - TipRanks
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket - Investing.com
Geron earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Geron earnings beat, revenue topped estimates - Investing.com
Geron appoints Harout Semerjian as new CEO amid RYTELO expansion - Investing.com
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Geron Taps Former Novartis Hematology Leader as CEO: 30-Year Expert to Scale RYTELO Commercial Launch - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Holdings in Geron Corporation (NASDAQ:GERN) - Defense World
What is the dividend policy of Geron Corporation stockUnlock daily trading alerts for profits - Jammu Links News
What makes Geron Corporation stock price move sharplyExtraordinary earning power - Jammu Links News
Ball Corp Set to Report Q2 Earnings: What Lies Ahead for the Stock? - The Globe and Mail
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT - Insider Monkey
Geron to Announce Q2 2025 Financial Results and Host Conference Call on August 6 - AInvest
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
Commercial Stage Biotech Geron Sets Q2 Earnings Release: Key Financial Updates Coming August 6 - Stock Titan
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):